In a study by Jolanta Kwiatek-Majkusiak et al. [41], serum levels offerrimodulin and IL-6 were evaluated in PD patients, revealing significantlyelevated levels of both markers and a positive correlation between them. The gene discussed is IL6; the disease is Parkinson disease.